SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001161697-21-000345
Filing Date
2021-07-13
Accepted
2021-07-13 16:44:31
Documents
1
Period of Report
2021-07-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 FOR 07-06-2021 form_3.html 3  
1 FORM 3 FOR 07-06-2021 form_3.xml 3 2739
  Complete submission text file 0001161697-21-000345.txt   4367
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address
Sundaram Preethi (Reporting) CIK: 0001872422 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33057 | Film No.: 211088368